Tag: Biocorp
Biocorp completes a convertible bond issue of 2.5 million euros – 01/02/2023 at 08:38
(AOF) – Biocorp, a French company specializing in the development and manufacture of medical devices and injectable drug delivery systems, announces the issuance of convertible bonds under a contract entered…
Diabetes: Biocorp has obtained authorization to market its Mallya device in the United States – 07/12/2022 at 17:22
(AOF) – Biocorp, a French company specializing in the development and manufacture of medical devices and injectable drug delivery systems, announces today that it has received 510(K) clearance from the…
BIOCORP and NOVO NORDISK strengthen their partnership with a new agreement on the Mallya® connected device – 2022-10-26 at 07:30
Issoire, October 26, 2022, 7:30 a.m. CEST – BIOCORP (FR0012788065 – ALCOR / PEA‐PME eligible), a French company specializing in the development and manufacture of medical devices and injectable drug…
BIOCORP and MERCK KGAA, Darmstadt, Germany, sign a new partnership for smart drug delivery – 10/10/2022 at 07:30
• BIOCORP and Merck KGaA, Darmstadt, Germany, partner for the development and worldwide distribution of a specific version of Mallya for drug delivery devices • BIOCORP and Merck KGaA, Darmstadt,…
Biocorp and Merck KGaA sign new partnership for smart drug delivery – 10/10/2022 at 07:54
(AOF) – French healthcare company Biocorp and pharmaceutical group Merck KGaA, based in Darmstadt, Germany, are joining forces for the development and global distribution of a specific version of Mallya…
Biocorp: Collaboration agreement with Merck KGaA
Receive the value of the day selected by The data collected is essential for this processing and is intended for the relevant departments of BFM Bourse and, where applicable, its…
Biocorp: collaboration agreement with Merck KGaA
(CercleFinance.com) – Biocorp indicates that it has entered into an agreement with Merck KGaA for the development and supply of a specific version of its Mallya device as an accessory…
Merck KGaA: Collaboration agreement with Biocorp
Receive the value of the day selected by The data collected is essential for this processing and is intended for the relevant departments of BFM Bourse and, where applicable, its…
Biocorp: CE marking for the SoloSmart system – 09/19/2022 at 12:33
(CercleFinance.com) – Biocorp announced on Monday that it had obtained CE marking for its medical device intended for Sanofi’s insulin pens, thus paving the way for it to be marketed…
On the occasion of the EASD, BIOCORP announces the CE marking of SoloSmart®, a medical device intended for SANOFI’s Solostar® pens – 09/19/2022 at 07:30
• Obtaining regulatory approval opens the door to bringing SoloSmart® to market in the European Union Issoire (France), September 19, 2022, 7:30 a.m. CEST – BIOCORP (FR0012788065 – ALCOR /…
Biocorp: new partnership
By Alexandra Saintpierre Published on 07/21/2022 at 8:18 p.m. (Boursier.com) —…
Biocorp posts 20% growth in 2021
Subscribe for 1€ Unlimited access to all advice More than 800 stocks listed in Paris and abroad screened. To buy ? To sell ? What course objective? Our experts engage…